CYTK EBITDA | CYTOKINETICS, INCORPORATED

CYTOKINETICS, INCORPORATED (CYTK) EBITDA

2026-06-30: Basis Reported; EBITDA -$175.54M*; Operating income -$179.17M; Depreciation and amortization $3.63M*.
2026-03-31: Basis Reported; EBITDA -$180.24M; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA -$175.51M; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA -$164.08M*; Operating income -$166.75M; Depreciation and amortization $2.68M*.

Complete source-backed ebitda history.

Available history: 2009-12-31 to 2026-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	-$175.54M*	-$179.17M	$3.63M*	$28.62M	-613.27%*	$4.33M*	-$159.84M*	(m)	$97.81M	$104.40M	(m)
2026-03-31	Reported	-$180.24M	(m)	(m)	(m)	-931.23%	$5.93M	-$145.46M	(m)	$95.53M	$104.90M	(m)
2025-12-31	Reported	-$175.51M	(m)	(m)	(m)	-988.48%	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	-$164.08M*	-$166.75M	$2.68M*	$1.94M	-8475.00%*	$9.35M*	-$107.50M*	(m)	$99.23M	(m)	(m)
2025-06-30	Reported	-$109.22M*	-$111.51M	$2.29M*	$66.77M	-163.58%*	$4.14M*	-$128.24M*	(m)	$110.14M	$65.72M	(m)
2025-03-31	Reported	-$153.33M	(m)	(m)	(m)	-9710.64%	$5.66M	-$131.62M	(m)	$98.26M	$57.37M	(m)
2024-12-31	Reported	-$136.66M	(m)	(m)	(m)	-807.33%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	-$138.39M*	-$140.80M	$2.41M*	$463.00K	-29889.85%*	$701.00K*	-$101.50M*	(m)	$84.61M	(m)	(m)
2024-06-30	Reported	-$127.77M*	-$130.17M	$2.41M*	$249.00K	-51311.65%*	$1.92M*	-$99.31M*	(m)	$79.60M	(m)	(m)
2024-03-31	Reported	-$123.9M	(m)	(m)	(m)	-14838.80%	$0.00	-$129.51M	(m)	$81.57M	(m)	(m)
2023-12-31	Reported	-$121.08M	(m)	(m)	(m)	-7241.81%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	-$120.41M*	-$122.27M	$1.85M*	$378.00K	-31854.76%*	$220.00K*	-$96.20M*	(m)	$82.53M	(m)	(m)
2023-06-30	Reported	-$120.19M*	-$122.05M	$1.85M*	$867.00K	-13863.21%*	$717.00K*	-$121.81M*	(m)	$83.19M	(m)	(m)
2023-03-31	Reported	-$122.63M	(m)	(m)	(m)	-2658.25%	$402.00K	-$122.29M	(m)	$79.42M	(m)	(m)
2022-12-31	Reported	-$125.37M	(m)	(m)	(m)	-6406.34%	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	-$107.03M*	-$108.44M	$1.41M*	$2.52M	-4255.79%*	$6.33M*	-$84.04M*	(m)	$62.73M	(m)	(m)
2022-06-30	Reported	-$9.47M*	-$10.87M	$1.41M*	$88.97M	-10.64%*	$857.00K*	-$90.47M*	(m)	$57.13M	(m)	(m)
2022-03-31	Reported	-$76.52M	(m)	(m)	(m)	-6665.16%	$942.00K	-$26.81M	(m)	$45.94M	(m)	(m)
2021-12-31	Reported	-$20.97M	(m)	(m)	(m)	-37.72%	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	-$68.74M*	-$69.20M	$462.00K*	$5.44M	-1264.28%*	$15.70M*	-$38.77M*	(m)	$48.44M	(m)	(m)
2021-06-30	Reported	-$54.25M*	-$54.80M	$543.00K*	$2.84M	-1908.34%*	$8.79M*	-$29.50M*	(m)	$36.44M	(m)	(m)
2021-03-31	Reported	-$40.07M	(m)	(m)	(m)	-612.00%	$6.63M	-$29.52M	(m)	$31.56M	(m)	(m)
2020-12-31	Reported	-$35.94M	(m)	(m)	(m)	-534.60%	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	$5.72M*	$5.18M	$536.00K*	$41.69M	13.72%*	$2.59M*	$14.37M*	(m)	$24.20M	(m)	(m)
2020-06-30	Reported	-$31.94M*	-$32.36M	$416.00K*	$3.59M	-889.01%*	$864.00K*	-$27.44M*	(m)	$21.79M	(m)	(m)
2020-03-31	Reported	-$29.95M	(m)	(m)	(m)	-783.11%	$1.04M	-$30.14M	(m)	$21.74M	(m)	(m)
2019-12-31	Reported	-$23.32M	(m)	(m)	(m)	-447.33%	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	-$23.59M*	-$23.93M	$336.00K*	$6.05M	-389.61%*	$1.01M*	-$20.27M*	(m)	$20.23M	(m)	(m)
2019-06-30	Reported	-$26.44M*	-$26.72M	$280.00K*	$7.14M	-370.41%*	$50.00K*	-$24.68M*	(m)	$24.02M	(m)	(m)
2019-03-31	Reported	-$24.23M	(m)	(m)	(m)	-286.29%	$257.00K	-$26.91M	(m)	$23.55M	(m)	(m)
2018-12-31	Reported	-$21.78M	(m)	(m)	(m)	-232.25%	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	-$17.65M*	-$17.91M	$268.00K*	$10.64M	-165.83%*	$358.00K*	-$32.23M*	(m)	$21.39M	(m)	$0.00
2018-06-30	Reported	-$22.80M*	-$23.41M	$618.00K*	$6.21M	-366.77%*	$60.00K*	-$26.85M*	(m)	$21.58M	(m)	$0.00
2018-03-31	Reported	-$25.46M	(m)	(m)	(m)	-483.26%	$261.00K	-$29.81M	(m)	$22.14M	(m)	$0.00
2017-09-30	Reported	(m)	-$28.42M	(m)	(m)	(m)	$451.00K*	-$25.48M*	(m)	$24.95M	(m)	$0.00
2017-06-30	Reported	-$24.75M*	-$25.19M	$439.00K*	(m)	(m)	$258.00K*	(m)	(m)	$19.81M	(m)	$0.00
2017-03-31	Reported	-$22.83M	(m)	(m)	(m)	-549.72%	$1.39M	(m)	(m)	$19.29M	(m)	$0.00
2016-12-31	Reported	$7.91M	(m)	(m)	(m)	23.88%	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	$34.14M*	$33.97M	$177.00K*	(m)	(m)	$306.00K*	(m)	(m)	$17.86M	(m)	$0.00
2016-06-30	Reported	-$10.84M*	-$11.01M	$170.00K*	(m)	(m)	$16.00K*	(m)	(m)	$9.72M	(m)	$0.00
2016-03-31	Reported	-$11.78M	(m)	(m)	(m)	-139.94%	$420.00K	(m)	(m)	$13.53M	(m)	$0.00
2015-12-31	Reported	-$8.87M	(m)	(m)	(m)	-90.91%	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	-$8.74M*	-$8.89M	$146.00K*	(m)	(m)	$53.00K*	(m)	(m)	$11.56M	(m)	$0.00
2015-06-30	Reported	-$10.44M*	-$10.59M	$147.00K*	(m)	(m)	$175.00K*	(m)	(m)	$12.64M	(m)	$0.00
2015-03-31	Reported	-$8.76M	(m)	(m)	(m)	-198.55%	$130.00K	(m)	(m)	$8.96M	(m)	$0.00
2014-12-31	Reported	$8.56M	(m)	(m)	(m)	39.33%	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	-$5.87M*	-$6.00M	$126.00K*	(m)	(m)	$100.00K*	(m)	(m)	$11.42M	(m)	$0.00
2014-06-30	Reported	-$8.29M*	-$8.41M	$122.00K*	(m)	(m)	$424.00K*	-$9.38M*	(m)	$11.74M	(m)	$0.00
2014-03-31	Reported	-$8.67M	(m)	(m)	(m)	-108.60%	$333.00K	-$17.82M	(m)	$12.49M	(m)	$0.00
2013-12-31	Reported	$6.52M	(m)	(m)	(m)	26.78%	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	-$12.51M*	-$12.61M	$101.00K*	(m)	(m)	$69.00K*	$10.31M*	(m)	$13.45M	(m)	(m)
2013-06-30	Reported	-$14.95M*	-$15.07M	$120.00K*	(m)	(m)	$44.00K*	$6.62M*	(m)	$12.35M	(m)	(m)
2013-03-31	Reported	-$12.52M	(m)	(m)	(m)	-1525.33%	$177.00K	-$12.22M	(m)	$9.83M	(m)	(m)
2012-12-31	Reported	-$11.36M	(m)	(m)	(m)	-520.15%	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Reported	-$9.93M*	-$10.07M	$140.00K*	(m)	(m)	$46.00K*	-$8.88M*	(m)	$8.80M	(m)	(m)
2012-06-30	Reported	-$8.81M*	-$8.96M	$144.00K*	(m)	(m)	$7.00K*	-$8.70M*	(m)	$8.24M	(m)	(m)
2012-03-31	Reported	-$9.76M	(m)	(m)	(m)	-536.37%	$13.00K	-$8.74M	(m)	$8.74M	(m)	(m)
2011-12-31	Reported	-$11.67M	(m)	(m)	(m)	-1541.35%	(m)	(m)	(m)	(m)	(m)	(m)
2011-09-30	Reported	-$10.41M*	-$10.67M	$255.00K*	(m)	(m)	$101.00K*	-$9.26M*	(m)	$8.89M	(m)	(m)
2011-06-30	Reported	-$13.26M*	-$13.65M	$390.00K*	(m)	(m)	$142.00K*	-$12.51M*	(m)	$10.51M	(m)	(m)
2011-03-31	Reported	-$11.33M	(m)	(m)	(m)	-1484.80%	$175.00K	-$12.88M	(m)	$9.18M	(m)	(m)
2010-12-31	Reported	-$11.17M	(m)	(m)	(m)	-1016.29%	(m)	(m)	(m)	(m)	(m)	(m)
2010-09-30	Reported	-$12.09M*	-$12.56M	$471.00K*	(m)	(m)	$132.00K*	-$10.32M*	(m)	$9.55M	(m)	-$176.00K
2010-06-30	Reported	(m)	-$13.15M	(m)	(m)	(m)	(m)	(m)	(m)	$10.24M	(m)	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	-$602.13M	(m)	(m)	(m)	-683.94%	$24.81M	-$510.01M	(m)	$416.03M	(m)	$0.00
2024-12-31	Reported	-$526.72M	(m)	(m)	(m)	-2851.13%	$3.91M	-$395.89M	(m)	$339.41M	(m)	$0.00
2023-12-31	Reported	-$484.31M	(m)	(m)	(m)	-6431.78%	$1.42M	-$414.33M	(m)	$330.12M	(m)	$0.00
2022-12-31	Reported	-$318.39M	(m)	(m)	(m)	-336.61%	$11.34M	-$299.52M	(m)	$240.81M	(m)	$0.00
2021-12-31	Reported	-$184.04M	(m)	(m)	(m)	-261.31%	$48.87M	-$142.52M	(m)	$159.94M	(m)	$0.00
2020-12-31	Reported	-$92.11M	(m)	(m)	(m)	-164.99%	$11.05M	$8.94M	(m)	$96.95M	(m)	$0.00
2019-12-31	Reported	-$97.57M	(m)	(m)	(m)	-363.16%	$2.62M	-$90.91M	(m)	$86.13M	(m)	$0.00
2018-12-31	Reported	-$87.68M	(m)	(m)	(m)	-278.33%	$889.00K	-$101.22M	(m)	$89.14M	(m)	$0.00
2017-12-31	Reported	-$111.48M	(m)	(m)	(m)	-833.90%	$2.88M	-$101.76M	(m)	$90.30M	(m)	$0.00
2016-12-31	Reported	$19.43M	(m)	(m)	(m)	18.26%	$1.60M	(m)	(m)	$59.90M	(m)	$0.00
2015-12-31	Reported	-$36.82M	(m)	(m)	(m)	-128.47%	$562.00K	(m)	(m)	$46.40M	(m)	$0.00
2014-12-31	Reported	-$14.26M	(m)	(m)	(m)	-30.39%	$1.10M	(m)	(m)	$44.43M	(m)	$0.00
2013-12-31	Reported	-$33.46M	(m)	(m)	(m)	-109.18%	$542.00K	-$7.72M	(m)	$49.45M	(m)	$0.00
2012-12-31	Reported	-$39.87M	(m)	(m)	(m)	-527.40%	$125.00K	-$33.44M	(m)	$35.64M	(m)	$0.00
2011-12-31	Reported	-$46.67M	(m)	(m)	(m)	-1166.67%	$443.00K	-$45.59M	(m)	$37.18M	(m)	$0.00
2010-12-31	Reported	-$47.74M	(m)	(m)	(m)	-1852.35%	$493.00K	-$44.83M	(m)	$38.01M	(m)	-$176.00K
2009-12-31	Reported	$28.12M	(m)	(m)	(m)	34.48%	$550.00K	$8.42M	(m)	$39.84M	(m)	$150.00K

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)	United States	$9.331B	-42.28
Protagonist Therapeutics, Inc (PTGX)	United States	$8.883B	95.52
TG THERAPEUTICS, INC. (TGTX)	United States	$8.805B	19.05
Axsome Therapeutics, Inc. (AXSM)	United States	$10.274B	-66.82
Praxis Precision Medicines, Inc. (PRAX)	United States	$7.884B	-27.60
Structure Therapeutics Inc. (GPCR)	United States	$7.710B	-53.41
Spyre Therapeutics, Inc. (SYRE)	United States	$7.685B	-43.69
IONIS PHARMACEUTICALS INC (IONS)	United States	$7.277B	-23.25
Elanco Animal Health Inc (ELAN)	United States	$11.177B	-61.80
Alkermes plc. (ALKS)		$6.844B	132.74